CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Sept. 03, 2020 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage diagnostics and genetic research company, today announced that ...

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Oct. 19, 2020 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world ...

Centogene, a commercial-stage company, and Fujirebio Europe announced to have entered a partnership to leverage Lumipulse G technology for large-scale COVID-19 antigen testing with further deployment ...

With the school start in Baden-Wuerttemberg the summer travel season ends in whole Germany. At the end of the summer, CENTOGENE and Lufthansa are taking a positive interim balance of the test centers ...

World leader and trusted partner in rare diseases releases enhanced Whole Exome Sequencing (WES) solution to improve diagnosis in complex and unsolved patient cases NEW CentoXome® provides ...

(RTTNews) - Shares of Centogene N.V. (CNTG) are rising more than 11% Monday morning after the company said it has received Emergency Use Authorization (EUA) from the FDA for 'CentoSure', the company's ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon ...

(RTTNews) - Shares of commercial-stage rare disease company Centogene N.V. (CNTG) are rising more than 11% Thursday morning at $13.35. It has been trading in the range of $7.80- $28.71 in the past ...

TORONTO, ONTARIO–(Marketwired – Feb. 19, 2014) – LifeLabs Medical Laboratory Services (“LifeLabs”) announced today the acquisition of Centogene AG’s (‘Centogene’) Canadian business. Based in Germany, ...

Publication demonstrates genome sequencing as the optimal standard for genetic testing Study presents the largest cohort of its kind with over 1,000 index cases Genome sequencing minimizes stepwise ...